Avectas

Avectas

Biotechnology Research

Dublin, Dublin 5,022 followers

Excelling beyond

About us

Avectas is accelerating the future of cell therapy with a flexible, easy-to-integrate delivery platform that manufactures healthier and more functional cells for patients. Excelling at complex editing and challenging cargo delivery, the Avectas non-viral delivery platform ensures the next generation of cell therapies can be realized. The Solupore non-viral delivery system enables the next generation of cell therapies through unparalleled cell health and superior cell functionality, expanding the possibilities for complex editing and challenging cargo delivery. Easy to integrate into existing GMP processes, Solupore accelerates the translation of life-saving therapies to patients.

Website
http://www.avectas.com
Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Dublin, Dublin
Type
Privately Held
Founded
2011
Specialties
Cell Engineering, Transfection, Cell Therapy, CAR-T, Gene Editing, Gene Therapy, and CRISPR

Locations

  • Primary

    Ground Floor Building 10,

    Cherrywood Business Park,

    Dublin, Dublin D18 T3Y1, IE

    Get directions
  • 245 First Street

    Suite 1800

    Cambridge, MA 02142, US

    Get directions

Employees at Avectas

Updates

Similar pages

Funding

Avectas 4 total rounds

Last Round

Grant

US$ 5.3M

See more info on crunchbase